Research prioritization based on expected value of partial perfect information: a case-study on interventions to increase uptake of breast cancer screening

被引:29
作者
Welton, N. J. [1 ]
Ades, A. E. [1 ]
Caldwell, D. M. [1 ]
Peters, T. J. [1 ]
机构
[1] Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England
基金
英国医学研究理事会;
关键词
Bayesian analysis; expected value of information; Markov chain Monte Carlo methods; research prioritization; sensitivity analysis;
D O I
10.1111/j.1467-985X.2008.00558.x
中图分类号
O1 [数学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 0701 ; 070101 ;
摘要
We investigate whether Bayesian decision theory, in the form of expected value of partial perfect information (EVPPI) analysis, is a realistic and practical approach to research prioritization. We develop a simple cost-effectiveness analysis of breast cancer screening as a typical case-study, motivated by data from a cluster randomized 2 x 2 factorial trial of interventions to increase uptake. An EVPPI analysis is developed which shows that, on the basis of the evidence that was available beforehand, the trial was cost effective, but that after incorporating the results of the trial it would still be cost effective to carry out research that further reduced decision uncertainty. We identify key conceptual and technical issues: the relationship between the target interventions and the previous evidence, the distinction between variation and uncertainty and methods for correlated parameters. EVPPI methods have clear advantages over current methods of research prioritization, but we suggest that some specific sensitivity analyses are required before they can be used confidently in practice. These have limitations, and there is a need to develop robust methods to optimize research portfolios.
引用
收藏
页码:807 / 834
页数:28
相关论文
共 65 条
[1]   The interpretation of random-effects meta-analysis in decision models [J].
Ades, AE ;
Lu, G ;
Higgins, JPT .
MEDICAL DECISION MAKING, 2005, 25 (06) :646-654
[2]   Expected value of sample information calculations in medical decision modeling [J].
Ades, AE ;
Lu, G ;
Claxton, K .
MEDICAL DECISION MAKING, 2004, 24 (02) :207-227
[3]  
BONFILL X, 2001, COCH LIB, V1
[4]  
Briggs A.H., 1999, HEALTH TECHNOL ASSES, V3, P2
[5]  
Briggs AH, 1999, HEALTH ECON, V8, P257, DOI 10.1002/(SICI)1099-1050(199905)8:3<257::AID-HEC427>3.0.CO
[6]  
2-E
[7]   General methods for monitoring convergence of iterative simulations [J].
Brooks, SP ;
Gelman, A .
JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS, 1998, 7 (04) :434-455
[8]   Need for differential discounting of costs and health effects in cost effectiveness analyses [J].
Brouwer, WBF ;
Niessen, LW ;
Postma, MJ ;
Rutten, FFH .
BRITISH MEDICAL JOURNAL, 2005, 331 (7514) :446-448
[9]  
Brown J, 2006, HEALTH ECON, V15, P435, DOI 10.1002/hec.1077
[10]  
CHILCOTT J, 2003, HLTH TECHNOL ASSESSM, V7